Apexbio Technology LLC YL-109 36341-25-0 10mg
YL-109 (CAS 36341-25-0) is a small molecule with demonstrated antitumor properties primarily acting through modulation of the aryl hydrocarbon receptor (AhR) signaling pathway This compound enhances expression of the molecular chaperone-associated ubiquitin ligase CHIP (C-terminus of Hsp70-interacting protein) leading to downstream regulation of processes implicated in cell proliferation and invasion In breast cancer models YL-109 induces CHIP expression resulting in suppressed proliferation and invasive capabilities of cancer cells YL-109 is thus a valuable tool for investigating AhR-mediated anticancer mechanisms and exploring therapeutic strategies in breast cancer research